View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Pharma Business Week

Susan Hasty, Publisher
Table of Contents . . . February 27th, 2006
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Pharma Business Week | Other Publications

Drug Development - Pharmacological improvements may help KRN633 beat diseases related to pathological angiogenesis

Market Analysis - Generics erosion will lead to slow market growth for chronic heart failure treatment

Market Analysis - Report finds every 1% increase in generic dispensing cuts pharmaceutical expenditures by 0.6%

Marketing - Market report says 2006 launch of cancer vaccine to prevent human papillomavirus expected

Pharmaceutical Research - Market research firm study shows companies spent more than $1 trillion on acquisitions in 2005

Addiction Medicine - Study supports a flexible approach to methadone dosing

Adverse Drug Reactions - Anticholinergic drugs linked to mental impairment in elderly people

Age-Related Macular Degeneration - European commission approves Macugen for treatment of all types of wet AMD

Allergy & Immunology - U.S. FDA approves Clarinex-D 12 Hour

Angina - U.S. FDA approves Ranexa

Antibiotics - In vitro, in vivo studies support development of pharmacodynamic parameters to determine drug dose

Antimicrobials - Second study to test persistency of chlorhexidine hand sanitizer commissioned in Europe

Asthma - Exercise induced asthma impacts 1 in 6 Olympic athletes

Attention Deficit Hyperactivity Disorder - Drugmaker provides update on regulatory status of Sparlon

Attention Deficit Hyperactivity Disorder - U.S. FDA accepts new drug application for NRP104 as treatment for ADHD

Avian Influenza - Applications of Hemopurifier expanded to include avian influenza

Avian Influenza - Safety issues may hamper production of bird flu vaccine

Awards - Kaiser Foundation, CNN International announce new award for HIV/AIDS journalism in Africa

Bacteriology - Studies report 2 million Americans carry drug-resistant Staph bacterium

Bioterrorism - Pharmaceutical firm responds to call for acute radiation syndrome therapy for U.S. forces

Bipolar Disorder - Course of bipolar disorder in children described for the first time

Bronchopulmonary Dysplasia - U.S. FDA grants Surfaxin fast track designation for prevention and treatment of BPD

Business & Finance - Allergan extends expiration date of exchange offer

Business & Finance - Cancer drug developer posts net loss of $0.17 per share

Business & Finance - Cancer drug developer reports loss of $0.23 per share

Business & Finance - Company reports Q4 revenue of $132.7M, discusses remarketing of Tysabri

Business & Finance - Drug delivery-focused company receives notice of AMEX delisting

Business & Finance - Drug development company subsidiary CDE certified for new market tax credit program

Business & Finance - Healthcare company announces transfer of manufacturing part of Erie operations to Mexico

Business & Finance - Hematology-focused biotech firm adopts shareholder rights plan

Business & Finance - Pharmaceutical company regains Nasdaq compliance

Business & Finance - Pharmaceutical company reports Q4 05 revenues of $437,000, down from $2.6 million in Q4 04

Business & Finance - Pharmaceutical company shareholders approve spinout of targeted immunotherapy assets

Business & Finance - Polymun development and manufacturing agreement sold for $1 million

Business & Finance - Protein, antibody developer reports net loss of $73.2M for 2005

Business & Finance - Specialty oncology company completes merger, raises $5.9 million in private financing

Business Update - Surgical products, services companies partner to target correctional health market

Business Update - Zoll Medical signs 3-year contract with Novation for noninvasive cardiac support pump

Cancer Research - Genetics research may hold key to destroying cancer cells

Cancer Screening - Pennsylvania governor proposes giving more women access to breast and cervical cancer screening

Cancer Therapy - Analysis of Genasense trial confirms major efficacy variables in patients with melanoma

Cancer Therapy - Cancer organization updates to several clinical practice guidelines

Cancer Therapy - Enrollment complete in pivotal phase III trial of FavId for follicular B-cell NHL

Cancer Therapy - Multicenter phase II study with MKC-1 begins

Cancer Therapy - Phase I trial of dendritic cell vaccine in patients with colorectal cancer meets endpoint

Cancer Therapy - Reports advance knowledge in cancer therapy research

Cancer Vaccines - Geron clarifies license rights for cancer vaccines

Cancer Vaccines - Researchers describe findings in cancer vaccines studies

Cardiology - Sirolimus-eluting stent may reduce re-blockage in complex coronary lesions, study shows

Cardiovascular Disease - Nearly half of people who need cholesterol treatment don't get it

Cardiovascular Disease - Pharma company introduces heart disease campaign to help women with physician conversations

Cardiovascular Therapy - Phase III study examines ability of drug to slow atherosclerosis

Central Nervous System - Glutamate receptor agonist may be an effective tool for investigating stress-related CNS disorders

Clinical Trials - Enrollment opened in phase 2 trial of DNA vaccine against cytomegalovirus

Clinical Trials - Medical centers vary in disclosing conflicts of interest to clinical trial subjects

Clinical Trials - Phase 2 program of antisense drug in patients with familial high cholesterol initiated

Clinical Trials - Plans for phase 2 trial of anticancer agent in elderly poor-risk AML patients announced

Collaborations - Abbott Laboratories grants rights for new cancer and transplantation drug tests

Collaborations - Advanced gene expression service provider expands globally

Collaborations - Alliance signed for promotion and support of clinical trials

Collaborations - Biosciences company, Bristol-Myers Squibb extend the term of research agreement

Collaborations - Collaboration formed to provide primate-human gene expression and SNP assays

Collaborations - Collaboration to develop ophthalmic therapeutics built from synergistic drug combinations

Collaborations - Commercialization deal signed for atherosclerosis treatment

Collaborations - Deal signed in Taiwan for development of Immunogene therapy for cancer indication

Collaborations - Licensing and commercialization agreements expanded into Europe for IGN311

Collaborations - Locus announces research agreement with Eli Lilly and Company for protein kinase target

Collaborations - Louisiana court partners with Southern University to evaluate substance abuse protocols

Collaborations - Partners form joint Center for Systems and Computational Biology

Collaborations - Partnership forged to develop new solutions for assessing drug toxicity

Collaborations - Partnership formed to develop RNAi therapeutics for childhood cancer

Collaborations - Research and development collaboration with Astellas Pharma extended

Contracts - Dialysis products manufacturer signs Canadian distribution agreement with Genpharm, Inc.

Cystic Fibrosis - Denufosol proceeding to phase III trials in cystic fibrosis

DNA Research - Single-step, single-nucleotide polymorphism typing based on DNA hole transport achieved

Depression - Findings advance knowledge in depression research

Depression - Women with major depression at risk of relapse during pregnancy without medication

Dermatology - Survey shows majority of Americans did not know that OTC products can make scars worse

Diabetes Drugs - Approval and availability of Avandaryl (rosiglitazone maleate and glimepiride) announced

Diabetes Pathogenesis - Leptin inhibits stimulation of fatty acid uptake by insulin in differentiated adipocytes

Diabetes Therapy - Shakuyakukanzoto effect in diabetics may rely on descending noradrenergic neuron activation

Diabetes Therapy - KCP256 shows lower drug-induced hypoglycemia risk compared with sulfonylurea drugs

Diagnostics - A new radioreceptor assay detects signs of angiogenic inhibition in preclinical models

Diagnostics - Label change granted for Thyrogen

Diet & Nutrition - Retailer launches Women's Ultra Mega Bone Density supplement

Disease Associations - High blood pressure, kidney disease increase heart disease risk in older Americans

Drug Delivery - European Commission approves IONSYS

Drug Development - APEX-AMI pexelizumab trial to complete enrollment in March

Drug Development - Access to investigational chickenpox product expanded to meet U.S. supply

Drug Development - Arixtra administered the morning after orthopedic surgery prevented VTE

Drug Development - Biologics license application for cervical cancer vaccine is on track

Drug Development - CD46-transgenic mice were used to study replication-incompetent adenoviral vectors

Drug Development - Data on Phenserine and Posiphen for Alzheimer disease to be presented in Geneva

Drug Development - Dosing cycle completed on first patient in phase I trial of blood cancer drug

Drug Development - Dr. Gerald Yakatan joins allergy company's board of directors

Drug Development - Drugmaker provides CIP-Tramadol Extended Release update

Drug Development - European Design Examination Certificate granted for wound care management product

Drug Development - Good bioavailability reported from phase I trial of iclaprim

Drug Development - Hepatitis C candidate moves into preclinical development

Drug Development - Human T cell leukemia virus type 1 protease is target for anticancer drug design

Drug Development - IND application filed for anticancer drug with nanotechnology delivery platform

Drug Development - Icon retained for phase II/III trial for MBP8298 to treat multiple sclerosis

Drug Development - LgsKO mice show higher glucose tolerance and lower adiposity without fasting hypoglycemia

Drug Development - Lundbeck, collaborator to discover allosteric modulators of G-protein coupled receptors

Drug Development - Maryland Industrial Partnerships program approves 14 university-based research projects

Drug Development - NDA submitted to U.S. FDA for involuntary emotional expression disorder therapy

Drug Development - New subsidiary to accelerate RNAi therapeutics programs

Drug Development - Pharma company in phase II trials of therapeutic for wet AMD

Drug Development - Pharma company initiates clinical trials of antisense drug in cancer patients

Drug Development - Pharma company receives milestone payment from Merck for ubiquitin ligases research

Drug Development - Pharmaceutical firm focused on diseases of aging and diabetes provides clinical pipeline update

Drug Development - Phase I trial initiated with c-Met inhibitor in patients with multiple metastatic tumors

Drug Development - Phase I trial of Type 2 diabetes drug initiated

Drug Development - Phase I trial underway of skin patch for prevention of chemo induced emesis

Drug Development - Phase II trial of Hematide initiated in patients with anemia associated with cancer

Drug Development - Phase II trial of MF101 launched for treatment of menopausal symptoms

Drug Development - Positive results reported in phase III study of Entereg in postoperative ileus

Drug Development - Predictive modeling software company introduces new product for pharma companies

Drug Development - Prescription product with nutritional components for osteoarthritis introduced nationally

Drug Development - U.S. FDA grants final approval for testosterone gel 1% product

Drug Development - U.S. FDA grants orphan medicinal product designation for rare disease protein therapeutic

Drug Development - U.S. FDA requests additional data for Delta opioid agonist; application on hold

Drug Safety - Chain-owned pharmacies less likely to provide prescription label translations

Drug Safety - Report on drug withdrawal in U.S. notes effect on selective COX-2 inhibitor market

Escherichia Coli Vaccines - Escherichia coli vaccine strain is safe and immunogenic in healthy adults

Facilities - Aptamer-based therapeutic developer moves to new headquarters

Facilities - Healthcare management systems company to open fifth medical facility in California

Facilities - Pharma company divests AWD.pharma manufacturing plant in Dresden, Germany

Facilities - Sigma-Aldrich Group member forms entity to provide raw manufacturing materials

Finance - Analytical instruments company reports Q4 2005 revenue growth of 21%

Finance - Biopharmaceutical company focused on metabolic diseases files shelf registration statement

Finance - Biopharmaceutical company reports 2005 U.S. and Canada net sales of anti-HIV drug up 32%

Finance - Canadian biopharmaceutical firm reports 9% increase in revenue

Finance - Cancer drug developer reports loss of $0.99 per share, provides clinical pipeline update

Finance - Cancer immunotherapies developer receives delist determination from NASDAQ panel

Finance - Cancer vaccine developer completes $3M institutional financing

Finance - Cancer-focused biotech firm announces put option

Finance - Cancer-focused biotechnology company sets IPO of common stock at $6 per share

Finance - Chemically derived drug distributor posts decline in revenue

Finance - Company focused on age-related macular degeneration receives investment

Finance - Connecticut to receive mental health state incentive grant of $13.6 million over 5 years

Finance - DNA-focused biopharmaceutical company files $70 million shelf registration

Finance - Drug developer focused on respiratory diseases reports 75% increase in sales

Finance - Drugstore chain reports 0.9% same store sales increase for January 2006

Finance - Gastroesophageal reflux disease drug developer completes Series E financing

Finance - Gastrointestinal drug maker reports 10% increase in sales

Finance - Healthcare products company reports Q4 05 net revenue up 2% to $4.7 billion

Finance - Healthcare, drug company reports GAAP net Q4 05 sales of $2.3 billion, up 6% from year ago

Finance - Healthcare, life sciences company reports Q3 2006 revenue increase of 5% to $287.5 million

Finance - Hearing aid company reports full year 2005 net sales up 7%, down 3% in Q4

Finance - Israel-based generic drug company sets pricing of $1.25 billion of convertible debentures

Finance - Kindred Healthcare announces $100 million increase to available credit capacity

Finance - Lilly reports $3.879 billion in sales

Finance - MedImmune reports revenues of $1.2 billion

Finance - Myeloma foundation awards over $8 million in 2005 to Multiple Myeloma Research Consortium

Finance - Mylan Laboratories reports earnings per share of $0.25 for third quarter

Finance - Natural and organic products company reports record Q2 2005 sales up 10% from year ago

Finance - Neurobiological Technologies receives $1.4 million quarterly royalty payment related to Memantine

Finance - Neuroscience drug maker receives $4.2M from exercise of warrants

Finance - Neuroscience drug maker reports loss of $0.10 per share

Finance - Nutritional products company reports net sales of $455 million for first quarter

Finance - Oncology diagnostics-focused company reports 2005 revenues increased 26% to $68.5 million

Finance - Ophthalmology company reports 10.7% increase in sales

Finance - OrthoLogic reports net loss of 7.5 million or $0.20 per share for the fourth quarter

Finance - Pharma company announces Tarceva net sales of $25 million for fourth quarter

Finance - Pharma company announces intention to raise $40 million in new capital

Finance - Pharma company begins trading under symbol NHPI, announces $4.35 million private placement

Finance - Pharma company sales increase 16% in 2005

Finance - Pharma firm focused on Asian markets receives American Stock Exchange notification

Finance - Pharma giant reports 1.1% decline in sales

Finance - Pharmaceutical company reports revenues up 13% for fiscal Q3 2006 over year ago

Finance - Pharmaceutical company sets pricing of initial public offering at $9 per share

Finance - Pharmaceutical division to be separated from parent company

Finance - Pharmaceutical firm files amended report to the U.S. S.E.C.

Finance - Protein therapeutics developer prices initial public offering

Finance - Public offering of common stock priced by RNAi therapeutics company

Finance - Q4 2005 sales of Copaxone up 24% to $323 million, annual sales up 26%, company reports

Finance - Risperdal Consta maker reports second consecutive profitable quarter

Finance - SBIR grant to be used for study of drug for stroke patients

Finance - Sierra Health reports Q4 2005 net income of $28.3 million, up from $28 million a year ago

Finance - Specialty pharma company signs definitive agreement for $65 million private financing

Finance - TEDCO awards grant for a smallpox DNA vaccine delivery project

Finance - United American Healthcare reports total revenues for Q2 2006 down from year ago

Finance - Walgreen Co. reports January 2006 sales increase 11.8% over same month 2005

Food Safety - EPA registration for germicidal product received by food safety products company

Food Safety - Human clinical trials commenced on citroxin 02 ingestible

Gastroenterology - Gut protein protects against infection, intestinal breakdown

Gastroenterology - U.S. FDA grants approval for oral treatment for chronic idiopathic constipation in adults

Gastroesophageal Reflux Disease - Medicare increases reimbursement rate for Plicator procedure

Generic Drugs - Drug maker announces Aventis' preliminary injunction motion denied in Allegra litigation

Generic Drugs - Pharma company announces final U.S. FDA approval for alprazolam extended-release tablets

Generic Drugs - U.S. FDA approves ANDA for generic desmopressin acetate tablets

Genetics & Genomics - Genetic variation detection tool used on mutations associated with therapy in lung cancer

Genetics & Genomics - RNAi Consortium member introduces lentiviral shRNA gene family set for gene silencing

HIV/AIDS Drug Delivery - HIV Tat fusion proteins reduce brain injury following ischemic stroke

HIV/AIDS Drug Development - LC method provides accurate and precise analysis of ritonavir in soft capsules

HIV/AIDS Pharmaceutical Research - Extended-release clarithromycin well tolerated and bioequivalent to IR formulation

HIV/AIDS Prevention - Call issued for Anglo-French alliance to combat AIDS epidemic

HIV/AIDS Prevention - Journal takes in-depth look at HIV/AIDS over the past 25 years

HIV/AIDS Therapy - Sequencing antiretroviral drugs extends the suppression of HIV replication

Health Promotion - New consumer education campaign focuses on immune system threats

Healthcare Access - Pennsylvania nonprofit organization launches for-profit seniors franchise system

Healthcare Costs - Administration says Medicare drug coverage will drop overall costs substantially

Healthcare Costs - Generic drug makers speak out against President Bush's budget

Healthcare Coverage - State of South Carolina selects ActiveHealth Management to provide decision support services

Healthcare Coverage - Studies reveal mandates requiring businesses to provide health coverage are ineffective

Healthcare Coverage - U. of Michigan health plan partners to offer online health management tools

Hepatitis B Virus - U.S. FDA approves hepatitis B-specific immune globulin for acute exposure

Hepatitis C Therapy - U.S. FDA grants Civacir fast track designation for hepatitis C

Hepatitis C Therapy - U.S. FDA grants fast track designation to investigational oral HCV protease inhibitor

Hepatitis C Virus - CD81 activates naive B lymphocytes

Hepatitis Vaccines - HBV CpG-optimized protein and DNA vaccines perform poorly in chimpanzees

Influenza - Copper could help prevent the spread of flu infections

Influenza - Thiovir proven active against various influenza A viruses

Information Technology - Company launches online course for lab staff on creating documents to meet ISO standards

Information Technology - FFF Enterprises uses ERP product-tracking software in electronic drug pedigree system

Information Technology - Partners In Care participates in federally funded test of electronic prescribing program

Information Technology - Sanofi-aventis Group signs 3-year software, services contract for sales management system

Information Technology - Software simplifies connectivity between logic analyzers and oscilloscopes

Japanese Encephalitis - European Commission grants Japanese encephalitis vaccine orphan drug status

Kidney Cancer - Agency approves new treatment for gastrointestinal and kidney cancer

Legal Issues - Molecular diagnostics company, Innogenetics reach agreement and resolve patent litigation

Leukemia - License agreement signed to develop Fodosine for use in oncology

Licensing Agreements - License agreement set with Baylor, M.D. Anderson to develop antimicrobial coated implants

Licensing Agreements - Potential migraine compound licensed to BTG

Macular Degeneration - Macugen receives European regulatory marketing approval as AMD treatment

Macular Degeneration - Phase I study of VEGF Trap shows rapid, substantial and prolonged reductions in retinal thickness

Market Analysis - China to become a world leader in stem cell research, according report

Market Analysis - U.S. has the largest over-the-counter drug market in the world, according to new report

Marketing - Ascend Therapeutics selects sales and marketing services provider to promote EstroGel

Marketing - Promotion "arms race" looks set to continue for the foreseeable future

Marketing - U.S. distribution rights for Medtronic anastomotic vascular surgery device acquired

Medical Devices - Immunoprofiling platform with global population coverage launched

Medicare - Pennsylvania governor seeks to expand comprehensive drug package for seniors

Medicare - U.S. HHS secretary issues progress report on Medicare Prescription Drug Benefit

Melanoma Vaccines - Research add new data to melanoma vaccines body of knowledge

Melanoma Vaccines - Researchers' work adds to melanoma vaccines body of knowledge

Menopause - New look at HRT highlights the value of starting soon after menopause

Mental Health - Lyrica receives positive opinion from CHMP for treatment of generalized anxiety disorder in adults

Mental Health - Men need lifestyle with work and play to prepare for retirement, Harvard publication says

Mental Health - Research firm finds launch of triple reuptake inhibitors will drive the market for depression

Mergers & Acquisitions - Agreement signed to acquire European drug discovery service company

Mergers & Acquisitions - Angiogenesis-focused biopharmaceutical firm merges with eClic, Inc.

Mergers & Acquisitions - Company focused on glaucoma acquires Pro Top and Mediking

Mergers & Acquisitions - Drug discovery company signs definitive agreement to acquire Montigen Pharmaceuticals

Mergers & Acquisitions - Final results of merger consideration regarding acquisition of Ivax announced

Mergers & Acquisitions - Innovate will acquire 50% interest in pancreatic chemoresistance inhibitor

Mergers & Acquisitions - Oncology services company to acquire ivpcare

Mergers & Acquisitions - Private equity firm acquires majority interest in Bioniche Pharma Group Limited

Mergers & Acquisitions - Purchase of continuing medical education company completed

Mergers & Acquisitions - Rapid testing devices developer announces acquisition of Accu-Stat Diagnostics, Inc.

Mergers & Acquisitions - Research firm acquires Millennium Research Group

Migraine Headaches - U.S. FDA approves new formulation of Imitrex injection

Muscular Dystrophy - Biopharma company initiates phase II study of PTC124 in Duchenne muscular dystrophy

Neuroscience - Research paper validates radioiodinated clioquinol as a biomarker for beta-amyloid

Obesity Epidemiology - Constant beta3-adrenoceptor stimulation by KTO-7924 improves lipid metabolism in obese rats

Oncology - Study emphasizes women should see gynecological oncologists for ovarian cancer treatment

Ophthalmology - U.S. FDA approves expanded use of Xibrom to treat post-cataract surgery pain

Ophthalmology - University eye institute, neurology program join to offer ophthalmology diagnostic program

Osteoporosis - CHMP recommends first quarterly IV for postmenopausal osteoporosis for approval

Osteoporosis - Pharma companies collaborate to develop and commercialize nasal spray for osteoporosis

Osteoporosis - Premenopausal women with diabetes have more fractures, less bone density, study shows

Osteoporosis - Researchers describe findings in osteoporosis studies

Pain Management - U.S. FDA accepts IND for OxyQD

Pain Management - U.S. FDA grants orphan drug status to high-concentration pain management therapy for PHN

Pancreatic Insufficiency - First of two phase III studies initiated for EUR-1008M in patients with EPI

Patents - Company receives second U.S. patent protecting polymer composition of delivery vehicle

Patents - Patent allowed for heat shock protein-derived peptides

Patents - Patent covers unique method of isolating adult stem cells

Patents - Pharma announces Federal Circuit Court of Appeals remands OxyContin patent case

Patents - Provectus receives fourth pharmaceutical patent for anticancer agents

Patents - Transdermal science company serves patent infringement notice for insulin delivery system

Pediatric Obesity - Women's volunteer group launches 2006 childhood obesity initiative "Kids in the Kitchen"

Pediatrics - New moms identify infant gas as stressor for babies and moms

Peripheral Arterial Disease - U.S. FDA fast track status granted for rifalazil in peripheral arterial disease

Personnel - Argeris 'Jerry' Karabelas named non-executive chair of drug delivery company board

Personnel - Biopharma company elects Jean-Pierre Millon as chairman of the board

Personnel - Biopharmaceutical company names Thomas E. Rathjen vice president of investor relations

Personnel - Biotech company names Neil Roth acting president

Personnel - Biotechnology Council of New Jersey's board of trustees elects Dr. Leslie J. Browne

Personnel - Chemistry service firm adds two key human resources professionals

Personnel - Clinical research organization adds three experts to global product development services group

Personnel - Contract research organization names Sara Vidmar executive director for medical devices

Personnel - David B. Nash, MD, and Bruce Morra, PhD, named to InforMedix, Inc. board

Personnel - Drug delivery pharmaceutical company announces workforce reduction

Personnel - Drug delivery systems company appoints Mento A. Soponis chairman and CEO

Personnel - Drug development software company adds staff in product training and strategic consulting services

Personnel - Duncan Higgons joins biopharma as executive vice president, business operations

Personnel - Former U.S. Surgeon General Joycelyn Elders joins pharmaceutical company

Personnel - George Pontiakos named president, CEO, North American operations, of nutrition company

Personnel - Infectious disease-focused pharmaceutical firm appoints chairman of the board

Personnel - Kenneth G. Faulkner named VP, business development, of clinical trials services company

Personnel - Molecular diagnostics company announces management team changes

Personnel - Nanomaterials developer hires Dr. Jayant Tatake as VP research and development

Personnel - Nasal drug delivery developer forms scientific advisory board

Personnel - New thoracic cancer advisory board formed

Personnel - Ophthalmology firm promotes F. Michael Ball to president

Personnel - Paul J. Gallagher named senior vice president, enterprise operations, of WellPoint, Inc.

Personnel - Peter Fellner named non-executive director at vaccines company

Personnel - Pharma company names Mark A. Varney as COO and chief scientific officer

Personnel - Pharma consulting company names Glenn A. Stiegman, III as vice president

Personnel - Pharma product development company appoints Rick A. Bright as VP vaccine research

Personnel - RNAi therapeutics-focused company appoints Akshay Vaishnaw as VP

Personnel - Radioisotopes company appoints Christopher Wagner as senior VP of sales and marketing

Personnel - Respiratory disease-focused drug maker appoints William J. Newell as president

Personnel - Rich Daly returns to pharma company as vice president of marketing and commercial strategy

Personnel - Robert F. Apple named senior VP and chief financial officer at drug delivery firm

Personnel - Sirtris names Garen Bohlin chief operating officer

Personnel - Walgreens names William M. Handal senior vice president of eastern store operations

Pertussis Vaccines - New data illuminates research in pertussis vaccines

Pharmaceutical Research - Drug delivery company, Donaldson launch jointly developed nanofiber cell culture product

Pharmaceutical Research - Market research firm introduces electronic format of Pharmcor report

Pharmaceutical Research - Phosphosulfomannan angiogenesis inhibitor analogues act variably

Philanthropy - Foundation receives grants from The Baxter International Foundation to help with disaster recovery

Pompe Disease - Biotech company receives positive opinion for Myozyme from European regulatory committee

Premenstrual Dysphoric Disorder - U.S. FDA clarifies status of YAZ PMDD application

Product Licensing - Beverly Hills California physician licenses Prometa physiological protocols

Product Licensing - Hepatitis C virus license agreement signed with Chiron

Product Licensing - Molecular tests company licenses newly discovered coronavirus CoV-NL63 to bioMerieux

Product Licensing - Pharma company licenses mitochondrial disease technology from Georgetown University

Product Licensing - Reproductive health organization licenses Biosyn-patented microbicides for the prevention of HIV

Product Licensing - Worldwide rights obtained for cetrorelix in benign prostate hyperplasia

Professional Education - Emergency nurses group selects online learning service to develop geriatric care course

Prostate Cancer - Data show bicalutamide 150mg plus radiotherapy extends survival in locally advanced prostate cancer

Protein Production - Multi-product immunoassays are suitable to monitor host cell protein impurities

Public Health - Campaign launched raise awareness of childhood cancer in emerging countries

Pulmonary Hypertension - Drugmaker in-licenses pulmonary hypertension compound for development

Respiratory Medicine - Group rankings shows no city is safe from asthma

Respiratory Medicine - Hydrocortisone therapy improves mechanical ventilator weaning

Rotavirus - Newly-licensed rotavirus vaccine traveled long road in development

Sexual & Reproductive Health - Soaring U.K. rates of Chlamydia infection partly due to more sensitive tests

Sleep Disorders - Regulatory update provided on status of NUVIGIL

Sociology Research - Bounded awareness, cognitive blinders can prevent risk recognition in decision making

Spinal Muscular Atrophy - Licensing agreement aims to boost spinal muscular atrophy drug discovery efforts

Staffing - Kenexa selects vendor for employment process outsourcing services

Staffing - Recruitment services firm establishes specialized healthcare group

Thyroid Cancer - U.S. FDA grants fast track designation for Zactima for the treatment of thyroid cancer

Tobacco Use - Healthcare supplier receives U.S. FDA approval to market nicotine lozenges

Tobacco Use - Low level laser therapy for smoking cessation clinic opens in New York City

Tonsillitis - Parents happier with alternative to liquid medications for tonsillectomy

Transplant Medicine - Findings describe new data in transplant medicine research

Transplant Medicine - Findings in transplant medicine provide new insights

Tuberculosis Vaccines - Advances in tuberculosis vaccine development summarized

Type 2 Diabetes - PC-DAC:Exendin-4 to advance into human clinical testing for type 2 diabetes

Ulcerative Colitis - European Medicines Agency CHMP recommends approval of Remicade for ulcerative colitis

Vaccine Development - Protection induced by BCG vaccine can be augmented using plasmid DNA

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx